Merck taps 5 Indian drugmakers to expand COVID-19 drug production

Merck taps 5 Indian drugmakers to expand COVID-19 drug production
By Reuters Staff1 Min ReadApril 27 (Reuters) - Merck & Co Inc said on Tuesday it had tied up with five generic drugmakers in India to expand access to molnupiravir, an experimental antiviral COVID-19 therapy it is developing with Ridgeback Biotherapeutics. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Ramakrishnan M.)Our Standards: The Thomson Reuters… Read More